Beta glucuronidase short-term immunotherapy prevents seasonal rhinoconjunctivitis in grass pollen allergic patients by modifying dendritic cell phenotype

被引：0
|
作者：
Di Stanislao, C
Angelini, F
Gagliardi, MC
Feccia, T
Di Berardino, L
Moschese, V
Chini, L
Polito, A
Riccardi, C
Rossi, P
机构：
[1] Dept Allergol, ASL 104, Laquila, Italy
[2] Tor Vergata Univ, Dept Pediat, Rome, Italy
[3] Childrens Hosp Bambino Gesu, Dept Pediat, Div Immunol & Infect Dis, Rome, Italy
来源：
ALLERGY | 2002年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [21] Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen (vol 32, pg 239, 2011)
    DuBuske, Lawrence M.
    Frew, Anthony J.
    Horak, Friedrich
    Keith, Paul K.
    Corrigan, Christopher J.
    Aberer, Werner
    Holdich, Tom
    von Weikersthal-Drachenberg, Karl J. Fischer
    ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (06) : 466 - 466
  • [22] Significant benefits of combined symptom and medication scores for ultra short course subcutaneous immunotherapy compared with placebo in patients with grass pollen allergic rhinoconjunctivitis
    Frew, A.
    DuBuske, L.
    Amersdorffer, J.
    Holdich, T.
    ALLERGY, 2009, 64 : 227 - 228
  • [23] Efficacy and safety of Artemisia annua sublingual immunotherapy in patients with seasonal allergic rhinoconjunctivitis over two pollen seasons
    Jiayi Yang
    Weidong Wang
    Zhen Shen
    Wei Kang
    Pengfei Zhang
    Xin Chen
    Huajing Li
    Yuan Shao
    Lifeng Liu
    Shaoqiang Zhang
    Fang Quan
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 4939 - 4947
  • [24] Efficacy and safety of Artemisia annua sublingual immunotherapy in patients with seasonal allergic rhinoconjunctivitis over two pollen seasons
    Yang, Jiayi
    Wang, Weidong
    Shen, Zhen
    Kang, Wei
    Zhang, Pengfei
    Chen, Xin
    Li, Huajing
    Shao, Yuan
    Liu, Lifeng
    Zhang, Shaoqiang
    Quan, Fang
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (11) : 4939 - 4947
  • [25] Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
    Malling, H-J.
    Montagut, A.
    Melac, M.
    Patriarca, G.
    Panzner, P.
    Seberova, E.
    Didier, A.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (03): : 387 - 393
  • [26] Proof of concept for a carry-over effect of co-seasonal SLIT in patients with grass pollen allergic rhinoconjunctivitis
    Ott, H.
    Sieber, J.
    Baron, J.
    Merk, H.
    ALLERGY, 2008, 63 : 146 - 147
  • [27] Intralymphatic immunotherapy reduced symptoms and improved quality of life of patients with grass pollen allergic rhinoconjunctivitis - a qualitative interview study
    Petersen, Poder A.
    Finderup, J.
    Schmid, J. M.
    Krogh, P. G.
    Hoffmann, H. J.
    ALLERGY, 2021, 76 : 87 - 87
  • [28] SQ-standardised grass allergy immunotherapy tablet treatment did not result in asthma worsening in subjects with allergic grass pollen rhinoconjunctivitis with or without seasonal asthma
    Dahl, R.
    Nolte, H.
    Nelson, H.
    Blaiss, M.
    Bufe, A.
    Rehm, D.
    Durham, S.
    ALLERGY, 2011, 66 : 301 - 301
  • [29] Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
    Verheggen, Bram G.
    Westerhout, Kirsten Y.
    Schreder, Carl H.
    Augustin, Matthias
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [30] SHORT-TERM EXPOSURE TO GRASS POLLEN IS ASSOCIATED WITH REDUCED LUNG FUNCTION IN CHILDREN WITH ALLERGIC DISEASE
    Idrose, Sabrina
    Vicendese, Don
    Koplin, Jennifer
    Peters, Rachel
    Douglass, Jo
    Newbigin, Ed
    Walters, E. Haydn
    Perret, Jennifer
    Tang, Mimi
    Lowe, Adrian
    Ponsonby, Anne-Louise
    Lodge, Caroline
    Dharmage, Shyamali
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 15 - 16
12345